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There is a growing desire within the chiropractic profession to expand the scope of practice to include limited
medication prescription rights for the treatment of spine-related and other musculoskeletal conditions. Such
prescribing rights have been successfully incorporated into a number of chiropractic jurisdictions worldwide. If
limited to a musculoskeletal scope, medication prescription rights have the potential to change the present role
of chiropractors within the healthcare system by paving the way for practitioners to become comprehensive
specialists in the conservative management of spine / musculoskeletal disorders. However, if the chiropractic
profession wishes to lobby to expand the scope of practice to include limited prescriptive authority, several
issues must first be addressed. These would include changes to chiropractic education and legislation, as well as
consideration of how such privileges could impact the chiropractic profession on a more theoretical basis. In this
commentary, we examine the arguments in favour of and against limited medication prescription rights for
chiropractors and discuss the implications of such privileges for the profession.
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Despite a growing number of surveys demonstrating a
positive attitude among chiropractors and patients to-
wards the limited use of medication within chiropractic
practice, chiropractors remain unable to prescribe medi-
cation in most parts of the world [1–8] (2007 and 2011
Ontario Chiropractic Association member surveys: B.
Haig; personal communication, 3 November 2014). In
many countries, chiropractors also lack direct access to
musculoskeletal (MSK) diagnostic imaging and labora-
tory testing – limitations that have real implications for
the clinician in accurately diagnosing and managing
their patient. Meanwhile, allied health care professions
such as optometry, chiropody, and naturopathy have
been steadily expanding their respective scopes’ of prac-
tice and gaining limited medication prescription rights
relevant to their areas of training and expertise [9–11].
Most notable for chiropractors is that physiotherapists* Correspondence: pcemary@hotmail.com
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authority in some countries [12, 13]. Moreover, there are
increasing examples of physiotherapists with advanced
training in medication prescription and diagnostic test-
ing who now manage patients with MSK disorders at
the primary care level [14–16].
Currently within the chiropractic profession, three
jurisdictions have incorporated the prescription of
limited medications into their scope of practice. These
include Switzerland [1], New Mexico (USA) [17], and
most recently, Liechtenstein (C. Mikus; personal com-
munication, 7 November 2015). In Switzerland and
Liechtenstein, the formularies are limited to analgesics,
anti-inflammatories, and muscle relaxants. Swiss chiro-
practors have had these privileges since 1995 [1], and
surveys have shown judicious use of this authority in
clinical practice [1, 4, 18, 19]. Along with these privileges,
chiropractors in Switzerland share primary care status
with general physicians in managing patients with spine-
related and other MSK complaints [18, 19]. As such,
limited prescriptive authority has generally been regardedle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Emary et al. Chiropractic & Manual Therapies  (2016) 24:33 Page 2 of 7by Swiss chiropractors as an advantage for the profession
in that country [1, 4].
In New Mexico, USA, the chiropractic formulary also
contains MSK medications; however, various hormones
and other injectable substances for treating non-MSK
disorders have been included [17]. Attempts have been
made by New Mexico chiropractors to further expand
this formulary to include additional prescription drugs
and injectable medicines for non-MSK conditions [20].
The motivation behind this push for broader prescriptive
authority appears to be that some chiropractors in New
Mexico [5] and elsewhere in the United States [21] wish
to become ‘primary care physicians.’ There is evidence
to suggest, however, that the medical and chiropractic
professions would largely oppose such an initiative
[6, 8, 11, 20, 22–24], while a collaborative role for
chiropractors as ‘primary MSK / spine care providers’
with limited prescriptive authority would be favoured
[11, 18, 25–30].
There is also a pressing issue in the chiropractic pro-
fession concerning the use of over-the-counter (OTC)
medication in clinical practice, which carries both clin-
ical and medico-legal implications. For instance, first line
medications suggested for uncomplicated back and neck
pain include analgesics, non-steroidal anti-inflammatory
drugs (NSAIDs), and/or muscle relaxants [31–38]. As
primary contact health care providers for spinal pain
and other MSK complaints, chiropractors may be asked
by their patients to make recommendations regarding
these medications. However, in most jurisdictions, recom-
mending or even giving advice on OTC medications is
currently outside of their current legislative scope of
practice. Regardless of this ‘barrier,’ there is evidence
to suggest that many practising chiropractors continue to
make OTC treatment recommendations to their patients
[6, 22, 23, 39].
In addition to legislative restrictions, there exists
significant contention within the profession as to whether
or not medication prescription even belongs in the chiro-
practic scope of practice [40–42]. Much of this disagree-
ment stems from philosophical differences within the
profession [6, 24]. Elements of this discord amongst chiro-
practors may also be reflective of the number of years in
practice, chiropractic college attended, or both [6, 8].
Regardless, with the exception of a few jurisdictions,
chiropractors have yet to establish full cultural authority
in society under the profession’s current international
‘drug-free’ model [43]. As such, further debate on the
issue of prescribing rights in chiropractic is warranted.
The objective of this commentary is to examine the
arguments in favour of and against limited medication
prescription rights for chiropractors and to discuss the
implications of such privileges for the profession. The
PubMed, Index to Chiropractic Literature (ICL), andCumulative Index to Nursing and Allied Health Litera-
ture (CINAHL) databases were searched, up to May 1,
2016 using a similar strategy as described previously
[40], in order to review the literature for this debate.
Additional reference articles that were not identified
through the literature searches but were pertinent to this
commentary were also included.
Discussion
Arguments in favour of limited medication prescription
rights for chiropractors
An important first argument in favour of granting lim-
ited medication prescription rights to chiropractors is
that these privileges would be in line with current
evidence-based practice. Currently, most international
guidelines recommend, alongside prescription medica-
tion, a course of manual therapy and/or exercise as well
as education and reassurance as part of a multi-modal
approach to managing various spine-related and other
MSK conditions [31, 33–38]. Regarding the effectiveness
of these and other individual conservative therapies, sev-
eral studies indicate that no one intervention is clearly
superior to another for managing acute MSK disorders
[44–46]. As such, if given limited prescription rights chi-
ropractors would gain access to an additional evidence-
based modality to effectively manage their patients. This
would allow chiropractors to select the most suitable
treatment modality, whether pharmacological or non-
pharmacological, based on available clinical evidence
and patient preference.
There is evidence to suggest that limited medication
prescription privileges would also be consistent with chi-
ropractors’ general experience and practice behaviour.
For instance, research findings from several studies indi-
cate that regardless of whether or not chiropractors
agree with medication prescription rights for the profes-
sion, many clinicians tend to recommend OTC medica-
tions to their patients in practice [6, 22, 23, 39]. From
surveys of chiropractors in Australia [22], the United
States [23], and Canada [6], between 66 and 87 % of re-
spondents indicated that they recommend non-prescription
analgesics and anti-inflammatories with variable frequency
to their patients.
Also in favour of medication prescription is that a
more comprehensive treatment approach offered by
chiropractors could potentially lead to a reduction in
healthcare costs by providing additional specialized
health care options for the treatment of MSK conditions.
Namely, if patients consult one central practitioner who
can effectively address and provide a range of treatment
modalities for MSK pain-related matters, the number of
visits to providers might be reduced, thereby resulting in
better resource allocation. In Switzerland, for example,
Houweling et al. [19] found clinically similar pain relief,
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health care costs in patients who initiated care with a
chiropractor versus a medical doctor for the treatment
of spinal, hip, and shoulder complaints. In situations
where patients present with more complex health prob-
lems, chiropractors in primary care could refer such
cases to a general physician or specialist for additional
examination and/or collaborative management. Such an
approach may also result in more streamlined care and
reduce waiting times for patients, thus improving the
overall quality and delivery of healthcare services.
Limited medication prescription rights could also lead
to improved cultural authority for chiropractors and bet-
ter integration within the healthcare system. Indeed, a
strong argument can be made that a profession skilled in
the art of manual therapy and possessing limited pre-
scriptive authority would have a significant role to play
in the evidence-based spine / MSK care marketplace.
Such an advancement has not only the potential of
benefiting patients, but also the chiropractic profession
as a whole by providing improved professional identity
and responsibility. In Switzerland, where the chiropractic
profession holds the privilege of limited medication pre-
scription within its scope of practice, chiropractors are
fully integrated into the healthcare system and have cul-
tural authority within the MSK domain [18, 19]. More-
over, the large majority of Swiss chiropractors perceive
these privileges as an advantage for the profession in
that country [1, 4]. In the United States, approximately
one-third of all licensed chiropractors currently practis-
ing in the state of New Mexico have limited prescriptive
authority. This formulary was approved in 2010 [17],
and to date there have been no associated injuries or pa-
tient complaints registered with the New Mexico Board
of Chiropractic Examiners (W. Doggett; personal com-
munication, 31 March 2016).
A final argument in favour of incorporating limited
medication prescription into the chiropractic scope of
practice is that with these privileges, chiropractors could
have a positive influence on public health. For instance,
analgesics and NSAIDs are widely used and potentially
misused by the general public [47–49], and users are
often unaware of the potential side effects that such
medication may cause [34, 47]. If granted limited pre-
scriptive authority, chiropractors would be in a position
to help advise patients against improper usage of these
types of medications. This notion is consistent with
current best-practice guidelines [31–38] and appears to
resonate with a large number of chiropractors [4, 6, 8,
24, 40, 41]. In two recent survey reports from Ontario,
Canada [6, 8], for example, between 68 and 72 % of
chiropractic respondents expressed interest in gaining
limited prescription privileges because of this potential
role for the profession.Arguments against limited medication prescription rights
for chiropractors
Although limited medication prescribing rights for chi-
ropractors may seem appealing to many, there are a
number of hurdles to overcome including political and
legislative challenges. These will not likely be easy to
surpass and may require much time and a united effort
on the part of the profession. In the United Kingdom,
for example, the physiotherapy profession campaigned
for nearly a decade before being granted limited inde-
pendent prescribing rights by the government in that
country [12]. For chiropractors, there will be major
changes needed before prescription rights can be incor-
porated into the profession’s scope of practice. Chiro-
practors and their governing bodies who wish to pursue
limited prescriptive rights for the chiropractic profession
should start reaching out to politicians and third-party
payers to promote the benefits of making such changes
to the existing healthcare system [26, 50]. Additional
research may be needed to better understand the conse-
quences of such changes and provide leverage for dis-
cussions with healthcare stakeholders.
Existing healthcare legislation needs to be amended in
order to regulate medication prescription by chiroprac-
tors. Both national and regional levels must be involved
so that patients and pharmacists know which medica-
tions are approved for prescribing by chiropractors and
which medications are covered by insurance policies.
Moreover, checklists should be designed to provide guid-
ance on safe medication prescription for different clinical
scenarios. These procedures may also assist chiropractors
in deciding when to communicate with other health care
practitioners so as to avoid multiple prescriptions for the
same patient complaint.
Notwithstanding the importance of such changes,
there is a need to focus on the curriculum of chiroprac-
tors. Inadequate knowledge and competence can result
in harm to patients; therefore, appropriate and robust
continuing education and training would be an absolute
requirement [51]. At present, most chiropractic students
internationally receive an average of only 12 h of course-
work in pharmacology and toxicology [52]. In contrast,
chiropractic students in Switzerland receive over 80 h in
pharmacology and toxicology at the University of Zürich
[6]. Clearly, there exists a need to revamp the under-
graduate pharmacology curriculum of non-Swiss chiro-
practic colleges if the profession wishes to lobby for
scope expansion including limited prescriptive authority.
Emphasis should not only be placed on didactic educa-
tion of prescribers, but also on practical supervision and
training by experienced tutors. This could be performed
by implementing a mandatory postgraduate program for
chiropractors including supervised experience in a clinical
setting. Such a program has been successfully implemented
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sion of an experienced chiropractor for a minimum of two
years, new chiropractic graduates are required to perform
clinical rotations at specialized hospital wards including
orthopedics, rheumatology, and physical medicine [53, 54].
Chiropractors who wish to practise in Liechtenstein must
also complete this same postgraduate training. In New
Mexico, USA, chiropractors must complete a two-year
postgraduate Master of Science degree in ‘Advanced Clin-
ical Practice’ [26, 55] before they can obtain a license to
prescribe from the limited chiropractic formulary in that
state [17]. A similar academic program is now being
proposed for chiropractors seeking legislative scope of
practice expansion with limited prescriptive authority in
the state of Wisconsin [26, 30].
Another important issue to consider regarding chiro-
practic prescribing rights relates to the divisiveness
around this topic within the profession. In fact, some
have argued that the right to prescribe medication in
chiropractic practice is the profession’s most divisive
issue [41]. While it may be true that chiropractors have
generally been split in their opinions concerning the
use of prescription medications in chiropractic practice
[40–42], there is evidence to suggest that this division
relates to differing philosophical ideologies within the pro-
fession and that those who are against gaining prescription
privileges for chiropractors are in the minority. For ex-
ample, in surveys [6, 24] of chiropractors in the United
States, Canada, and Mexico, the large majority of respon-
dents who classified themselves as practising within a
“broad” (or ‘mixer’) scope of chiropractic practice were in
favour of the idea of gaining prescriptive rights while the
large majority of those who identified themselves as “fo-
cused scope” (or ‘straight’) chiropractors were opposed.
Broad scope chiropractors made up approximately one-
third of the respondents in these studies compared to
focused scope chiropractors who made up less than two-
fifths. Of the remaining and largest group of “middle
scope” respondents, the majority also favoured chiroprac-
tic prescribing rights [6, 24]. This indicates that there may
be potential for consensus among the majority of chiro-
practors regarding medication prescription rights for the
profession. Interestingly, focused scope respondents were
not unanimously opposed to the notion of chiropractic
prescribing rights in these studies. In fact, between 18 and
24 % of focused scope chiropractors indicated at least
some level of support for limited (i.e. MSK) medication
prescription privileges [6, 24]. These findings demonstrate
that there is potential for unity on this topic within the
profession.
Irrespective of philosophical differences, there is evi-
dence to suggest that there could be a shift in chiroprac-
tors’ attitudes toward medication prescription rights
occurring within the profession in general. In particular,results from a growing number of surveys indicate that
chiropractic clinicians who are interested in prescription
rights seem to be most in favour of gaining an expanded
scope to allow for the limited prescription of medica-
tions for common MSK conditions. In various surveys of
chiropractors practising in Australia, the United States,
Canada, Mexico, and the United Kingdom, majorities of
between 54 and 78 % of respondents expressed interest
in the expansion of scope of practice, including the
addition of prescriptive authority for a select number of
medications such as NSAIDs, analgesics, and muscle
relaxants [2, 3, 6–8, 22–24] (2007 and 2011 Ontario
Chiropractic Association member surveys: B. Haig;
personal communication, 3 November 2014). Various
chiropractors and chiropractic associations have also
published a number of recent policy statements, commen-
taries, and policy papers [25, 26, 50, 56, 57] calling for
similar legislative changes to the chiropractic scope of
practice, reiterating that the profession may not be as di-
vided on this topic as previously thought [40–42]. Owing
to the fact that several of the aforementioned surveys were
unpublished [2, 3, 7] (2007 and 2011 Ontario Chiropractic
Association member surveys: B. Haig; personal communi-
cation, 3 November 2014) or were limited by low response
rates [6, 8, 22–24], these findings should be interpreted
carefully.
An issue often raised concerning chiropractic prescrib-
ing rights relates to the influence these privileges could
have on the profession’s identity. For instance, through-
out most of its 120-year history the chiropractic profes-
sion has presented itself as a drugless, non-surgical
healing profession [40]. Some have argued that further
incorporation of prescription rights into the chiropractic
scope of practice will negatively impact the distinct pro-
fessional brand and identity of chiropractic [41]. Others
have argued however that chiropractic has always lacked
a clear professional identity, resulting in its failure to estab-
lish full cultural authority and respect within mainstream
society [25, 57–59].
Aside from ideological and philosophical barriers, a
further argument against introducing limited medication
prescription rights into the chiropractic scope of practice
is that such privileges would increase chiropractors’ pro-
fessional responsibilities. For example, if given limited
prescriptive authority, chiropractors would be required
to recognize and monitor medication side effects in their
patients [60]. Additional implications would include ne-
cessary increases to a practitioner’s liability insurance
coverage as well as potential conflict of interest/ethical
issues related to dispensing and/or selling prescribed
medications [11]. For instance, it is well-documented
that prescribing practices can be influenced through par-
ticipating in continuing education programs funded by
pharmaceutical companies [61, 62]. These additional
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drawbacks for a number of chiropractic clinicians.
Prior to medication prescription rights being incorpo-
rated into the chiropractic scope of practice worldwide,
further discussions need to take place around the
breadth of such privileges for the chiropractic profes-
sion. For instance, although there may be a growing
interest among chiropractors internationally towards
gaining limited prescriptive privileges for treating MSK
conditions, there does not seem to be the same level of
support within the profession concerning that of full
prescribing rights. From results of several published
surveys [6, 8, 22–24] of chiropractors in Australia, the
United States, North America, and Canada, respondents
have generally been opposed to the idea of chiropractors
prescribing medicines for non-MSK conditions. Practising
chiropractors have also indicated that their knowledge of
these types of medications is insufficient [6]. Some chiro-
practors and educational institutions in the United States
nevertheless appear to be lobbying for expanded scope of
practice legislation in order for chiropractors to become
primary care physicians with full prescriptive authority
[20, 21]. However, research suggests that only a small mi-
nority of chiropractors in clinical practice would actually
be interested in a plenary scope [6, 24]. For example, in
their survey, Emary and Stuber [6] found only 11.6 %
(111/960) of respondents agreed that chiropractors should
be able to gain an expanded scope of practice to allow for
the prescription of any and all medications, including
controlled substances. Similar results were found by
McDonald et al. [24] in their survey of practising chiro-
practors from North America. One possible solution to
this problem would be for chiropractic regulatory boards
to limit medication prescription privileges to analgesics,
NSAIDS, and muscle relaxants, such as is the case for
chiropractors in Switzerland and Liechtenstein, so as to
focus on treatment modalities that are compatible with
chiropractic practice.
Conclusions
The right to prescribe medication in chiropractic prac-
tice may not be as divisive an issue within the profession
as previously thought. In particular, there appears to be
a growing interest among chiropractic clinicians towards
gaining prescription privileges for treating spine-related
and other MSK conditions. If limited to such a scope,
prescription rights for chiropractors would be in line
with current evidence-based practice, common chiroprac-
tic practice behaviour, and interdisciplinary collaboration
with medical doctors. Moreover, limited chiropractic
prescribing rights could result in significant health
cost savings, strengthening of the chiropractic pro-
fession, and an overall positive influence on public
health.Although prescription rights may seem appealing to
many in the chiropractic profession, major changes to
education and legislation will first be needed before
these privileges can be incorporated into the profession’s
scope of practice. Chiropractors and the governing bod-
ies that wish to pursue limited prescriptive authority
should engage in dialogue with like-minded politicians
and third-party payers and promote the benefits of making
such changes to the existing healthcare system. In addition,
future research might be needed in order to justify such
discussions with healthcare stakeholders.
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